Biotechnology is a frontline area of science with immense potential for the benefit of humankind. Borne out of the Cradle of Humankind (Africa), our company is a pioneering biotech firm that was established in South Africa as a research project in 2015.
In 2018, we launched Capebio™ Technologies (Capebio™SA) as a 100% privately owned company.
At Capebio™SA, we mine microbial data from unique African microbial ecosystems in search of genetic material that codes for novel biomolecules (e.g., enzymes, proteins and peptides).
We use OUR PROPRIETARY ARTIFICIAL INTELLIGENCE PLATFORM to discover and develop these molecules with precision, acceleration and sureness before downstream developmental processes.
To develop the “best-in-class” healthcare solutions in Africa, for Africa and the world.
To create excellent innovations that improve the quality of life in Africa and beyond.
Integrity, Accountability, Responsible Innovation, Diversity, and Inclusion.